Affimed Ord Shs (NQ: AFMD )
4.150
-0.060
(-1.43%)
Streaming Delayed Price
Updated: 11:20 AM EDT, Aug 26, 2024
Add to My Watchlist
All News about Affimed Ord Shs
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/image-starbucks.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8356.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4172.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3201.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/99c876b1-329f-4ef7-8a91-a8d0dc003628/small/affimed-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/99c876b1-329f-4ef7-8a91-a8d0dc003628/small/affimed-logo-jpg.jpg)
Affimed to Present at the 2022 Jefferies London Healthcare Conference
November 01, 2022
From Affimed N.V.
Via GlobeNewswire
![](https://g.foolcdn.com/editorial/images/704299/person-in-a-lab-looking-through-a-microscope.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5266.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/10/image-dominos.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/99c876b1-329f-4ef7-8a91-a8d0dc003628/small/affimed-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4537.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://investorplace.com/wp-content/uploads/2019/07/blue-chip-closeup.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_9878.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4168.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_3303.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/13/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/04/11/aapharma_29.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/cells-gdd37bc5d2_1920_20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_1791.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5926.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/lab-5740505_1920_14.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3199.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_580.png)
![](https://cdn.benzinga.com/files/images/story/2012/biotech_6.jpg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.